Clinical Trials Logo

Filter by:
NCT ID: NCT04604457 Completed - Palliative Care Clinical Trials

Impact of Predictive Modeling on Time to Palliative Care in an Outpatient Primary Care Population

Start date: August 31, 2020
Phase: N/A
Study type: Interventional

A machine learning algorithm will be used to accurately identify patients in certain primary care units who may benefit from palliative care consults.

NCT ID: NCT04604236 Completed - Clinical trials for Mapping Enhanced Counseling (MEC)

Family Assessment Motivation, and Linkage Intervention (FAMLI)

FAMLI
Start date: July 7, 2022
Phase: N/A
Study type: Interventional

The R34 study will integrate existing tools for use with JJ populations and examine the feasibility, acceptability, and preliminary efficacy of a caregiver-youth intervention aimed at increasing SU treatment initiation. The adaptive intervention incorporates three evidence-based components: 1) assessment of motivation and linkage-related barriers with personalized feedback, 2) Mapping-Enhanced Counseling (MEC) for improving readiness for change and interpersonal communication, and 3) Active Linkage (AL) for addressing logistical barriers to service initiation. Youth-caregiver dyads will be randomly assigned to receive an initial dose (2, 1-hr sessions) of either MEC or AL. After 30 days, participants will be classified as Responders (1 or more services initiated) or Non-responders (no service initiation). All participants will be randomized to one of two intervening interventions: an additional dose (2, 1-hr sessions) of the initial intervention (MEC or AL) or a different dose (2, 1-hr sessions of the other). The specific aims are to 1) integrate and adapt appropriate evidence-based intervention components as a dyadic intervention approach for JJ youth and caregivers; 2) test the feasibility, acceptability, and optimal configuration of the dyadic intervention components and the protocol used to evaluate effectiveness (including feasibility of recruitment, implementation, measurement); and 3) preliminarily explore a) whether an initial dose of MEC or AL is sufficient for promoting early initiation and engagement, b) whether an additional dose of MEC or AL or a change in dose is more effective, and c) which component sequence is most effective. Primary outcomes include youth (initiation of assessment or counseling; counseling attendance) and caregiver (attendance at assessment, first counseling, and/or family sessions) measures. Secondary outcomes include youth and caregiver attitudes (problem recognition, desire for help), normative beliefs (SU norms), perceived control (stressors and obstacles), and youth SU (self-report corroborated by UA results). The study addresses the sizeable gap in service receipt among JJ youth by addressing family engagement, and focuses on improving motivation to change, linkage to services, and treatment engagement.

NCT ID: NCT04604210 Completed - Depression Clinical Trials

Symptom-specific TMS Targets for Depression and Anxiety

Start date: February 3, 2021
Phase: Phase 2
Study type: Interventional

This pilot study aims to compare two different treatment targets for transcranial magnetic stimulation, an FDA-approved treatment for major depressive disorder (MDD), in terms of their relative efficacy for depression versus anxiety.

NCT ID: NCT04604158 Completed - Breast Cancer Clinical Trials

Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients

Start date: December 2, 2020
Phase: N/A
Study type: Interventional

This is a single-arm, prospective, interventional study in cancer survivors and patients to examine the feasibility of a mobile health application, Elly (Elly Health Inc.), to reduce levels of anxiety, stress, loneliness, and social isolation. Participants will be given access to the Elly phone application developed by Elly Health Inc. and will be asked to complete questionnaires measuring quality of life at multiple timepoints during the study.

NCT ID: NCT04604145 Completed - SARS-CoV Infection Clinical Trials

Self-Collected Saliva Samples Without Viral Transport Media for COVID-19 Testing Via RT-PCR

Start date: February 3, 2021
Phase: N/A
Study type: Interventional

This is a study that will attempt to validate the process for detecting SARS-CoV-2 (COVID19) on a non-FDA-approved technology using self-collected saliva as the specimen. Investigators will compare self-collected saliva samples and healthcare-worker collected nasopharyngeal samples (Nasal swabs) to see if the self-collected saliva samples are similar in terms of diagnostic accuracy. Investigators will be performing this testing at the site where patients regularly go for COVID19 testing. There will be minimal risk of harm as consenting patients will only have to provide a small amount of saliva into a tube.

NCT ID: NCT04604093 Completed - Diabetes Mellitus Clinical Trials

Effect of the FreeStyle Libre 2 Flash Glucose Monitoring System on Hyperglycemia in People With T2 Diabetes

Start date: October 20, 2020
Phase:
Study type: Observational

A multi-center, randomized, prospective, non-significant risk study to compare the impact of the FreeStyle Libre 2 Flash Glucose Monitoring System to the current standard of care (SMBG, self-monitoring of blood glucose) on reducing time above 180 mg/dL in subjects with type 2 diabetes who are not adequately controlled on their existing oral anti-diabetes medication regimen.

NCT ID: NCT04604015 Completed - Clinical trials for Transient Ischemic Attack

RoBotic TCD Ultrasound BubbLe Study Compared to Transthoracic Echocardiography for Detection of Right to Left Shunt

BUBL
Start date: October 6, 2020
Phase: N/A
Study type: Interventional

This study is a multi-center, prospective, single-arm, non-significant risk (NSR) device study in which up to 150 evaluable subjects with suspicion of embolic stroke of undetermined source (ESUS) will be evaluated with NB-IS TCD and standard of care TTE to screen for right to left shunt (RLS) or patent foramen ovale (PFO). Additionally, up to 150 evaluable subjects will be evaluated with NB-IS TCD and standard of care TEE.

NCT ID: NCT04604002 Completed - Retinal Vascular Clinical Trials

Evaluation of Additional Heidelberg Engineering SPECTRALIS With OCT Angiography Module (OCTA Module) Scan Types

OCTA
Start date: October 15, 2020
Phase:
Study type: Observational

Assessment of image quality and clinical relevance of OCT Angiography at different speed/ART combinations

NCT ID: NCT04603924 Completed - COVID-19 Clinical Trials

Study of Niclosamide in Moderate and Severe Hospitalized Coronavirus-19 (COVID-19) Patients

Start date: October 7, 2020
Phase: Phase 2/Phase 3
Study type: Interventional

Study of ANA001 in Moderate and Severe COVID-19 Patients

NCT ID: NCT04603677 Completed - Covid19 Clinical Trials

Northern Colorado COVID-19 Biobank

NoCo-CoBio
Start date: July 8, 2020
Phase:
Study type: Observational

The NoCo-CoBio Project is a biobanking effort to store and preserve saliva, nasopharyngeal, stool and blood specimens from SARS-CoV-2 PCR (polymerase chain reaction) positive individuals.